Invacare Corporation logo
Invacare Corporation IVC

Quarterly report 2023-Q1
added 05-15-2023

report update icon

Invacare Corporation Income Statement 2011-2026 | IVC

Annual Income Statement Invacare Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

24.1 M 78.5 M 321 M 274 M 173 M 606 M 369 M 496 M 469 M 681 M 533 M 536 M

Shares

36.5 M 34.9 M 34.3 M 33.6 M 33.1 M 32.8 M 32.5 M 32.2 M 32 M 31.9 M 31.6 M 32 M

Historical Prices

0.66 2.25 9.36 7.66 5.08 18.1 11.3 15.1 14.3 19.6 15.2 16.5

Net Income

-20.6 M 1.94 M -28.3 M -53.3 M -43.9 M -76.5 M -42.9 M -26.2 M -56.1 M 33.1 M 1.83 M -4.11 M

Revenue

181 M 226 M 851 M 928 M 972 M 966 M 1.05 B 1.14 B 1.27 B 1.35 B 1.46 B 1.8 B

Cost of Revenue

566 M 633 M 605 M 666 M 705 M 697 M 764 M 830 M 923 M 967 M 989 M -

Gross Profit

48.3 M 63.3 M 245 M 262 M 268 M 269 M 284 M 313 M 347 M 377 M 445 M 518 M

Operating Income

-80.5 M -24.2 M 11.3 M -10.4 M -18.3 M -40.2 M -15.2 M -7.77 M -58.8 M - - -

Interest Expense

28.5 M 24.3 M 28.5 M 29.1 M 28.3 M 22.9 M 15.9 M 4.14 M 4.89 M 3.08 M 7.74 M -8.89 M

EBITDA

-65 M -7.41 M 25.6 M 26.5 M 1.33 M -12.9 M -5.52 M 12.4 M -3.74 M 12.4 M 69 M 111 M

Operating Expenses

- - - 260 M 282 M 297 M 304 M 320 M 384 M 402 M 415 M 446 M

General and Administrative Expenses

227 M 232 M 236 M 260 M 282 M 297 M 304 M 320 M 384 M 402 M 415 M 422 M

All numbers in USD currency

Quarterly Income Statement Invacare Corporation

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

38 M - 37.5 M 35.6 M 35 M - 35 M 35 M 34.5 M - 34.4 M 34.4 M 34.1 M - 33.7 M 33.7 M 33.3 M - 33.2 M 33.2 M 32.9 M - 32.9 M 32.8 M 32.5 M - 32.5 M 32.2 M 32.4 M - 32.2 M 32.1 M 32.1 M - 32 M 32 M 32 M - 31.9 M 31.9 M 31.9 M - 31.9 M 31.8 M 31.8 M - 31.9 M 32 M 32.2 M

Net Income

-41.2 M - -34.4 M -21.9 M -24.2 M 1.94 M -22.8 M -10.7 M -14 M -5.12 M -7.28 M -16.6 M -16.6 M -18.7 M -8.04 M -12.7 M -13.9 M -1.24 M -12 M -16.5 M -14.1 M -17.7 M -18.6 M -23.5 M -16.8 M -17.6 M -5.02 M -11.6 M -8.62 M -2.93 M -7.79 M -8.22 M -7.25 M -9.38 M -15.1 M -13.6 M -18 M -5.77 M 16.1 M -12.5 M 35.2 M -7.29 M 2.86 M -1.98 M 8.23 M -35 M 12.8 M 10.7 M 7.45 M

Revenue

165 M - 170 M 189 M 201 M 226 M 224 M 226 M 196 M 224 M 212 M 196 M 196 M 233 M 113 K 119 K 129 K 245 M 85 K 136 K 249 K 250 M 137 K 49 K 88 K 247 M 79 K 74 K 54 K 283 M 42 K 42 K 38 K 318 M 38 K 323 K 68 K 331 M 58 K 74 K 107 K 355 M 166 K 143 K 301 K 374 M 625 K 279 K 267 K

Cost of Revenue

122 M - 139 M 141 M 153 M - 164 M 165 M 142 M - 152 M 140 M 295 M - 168 M 171 M 162 M - 179 M 179 M 171 M - 180 M 168 M 167 M - 195 M 201 M 190 M - 206 M 209 M 212 M - 236 M 235 M 222 M - 242 M - - - - - - - - - -

Gross Profit

43.8 M - 31.4 M 48 M 47.7 M 63.3 M 60.3 M 60.8 M 54.6 M 65.6 M 60 M 56.6 M 56.6 M 68 M 67.6 M 65.1 M 61.5 M 68.2 M 65.6 M 67.3 M 66.5 M 68.3 M 70.7 M 65 M 65.1 M 68.7 M 73.4 M 73.6 M 67.9 M 80.8 M 77.6 M 77.3 M 77.1 M 88.4 M 84.6 M 91.6 M 82.8 M 91.3 M 94.2 M 90.9 M 91 M 105 M 109 M 113 M 109 M 120 M 122 M 125 M 114 M

Operating Income

-10.4 M - -33.4 M -14.8 M -16.6 M - -24.8 M -3.49 M -5.74 M - 2.93 M -2.24 M 7.21 M - 2.42 M -4.51 M -4.48 M - -5.28 M -6.76 M -5.15 M - -5.88 M -15.7 M -10.7 M - 2.62 M -5.82 M -5.08 M - 189 K -5.82 M -4.38 M - - - - - - - - - - - - - - - -

Interest Expense

9.1 M - 7.35 M 6.23 M 6.25 M - 6.28 M 6.08 M 5.73 M - 7.4 M 7.05 M 13.7 M - 6.99 M 7.72 M 7.31 M - 7.12 M 6.96 M 6.96 M - 6.84 M 4.64 M 4.52 M - 4.48 M 4.37 M 2.37 M - 1.02 M 710 K 692 K - 549 K 1.05 M 689 K - 639 K -741 K -1.01 M - -1.95 M -2.16 M -2.05 M - -1.02 M -1.95 M -2.34 M

EBITDA

-6.88 M - -21.6 M -6.95 M -12.7 M - -12.3 M 4.77 M -1.66 M - 13.3 M -2.24 M 13.9 M - 14.2 M 3.3 M -580 K - 6.7 M 939 K -1.04 M - 5.07 M -8.37 M -7.06 M - 13.5 M 1.45 M -1.42 M - 13.8 M 4.62 M 968 K - 26.4 M 18.2 M 9.51 M - 28.2 M 18.9 M 8.85 M - 29.1 M 19.4 M 9.63 M - 27.6 M 18.1 M 8.8 M

General and Administrative Expenses

53.8 M - 55.4 M 58.6 M 60.6 M - 56.1 M 63.8 M 58.8 M - 55.5 M 57.4 M 119 M - 63.5 M 68.3 M 65.2 M - 69.9 M 73.8 M 71.3 M - 75.9 M 75.7 M 72.5 M - 77.7 M 78.7 M 72.8 M - 77.5 M 82.4 M 81.2 M - 98.2 M 100 M 96.8 M - 97.6 M 104 M 103 M - 103 M 104 M 101 M - 104 M 112 M 106 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company Invacare Corporation (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
FONAR Corporation FONAR Corporation
FONR
$ 18.59 -0.08 % $ 122 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Globus Medical Globus Medical
GMED
$ 89.93 1.5 % $ 12.2 B usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 11.93 -1.16 % $ 1.61 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 8.97 -4.37 % $ 254 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 1.81 -4.74 % $ 1.1 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.28 -0.32 % $ 715 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 36.52 -0.6 % $ 5.44 K usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.03 3.75 % $ 17.4 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 85.18 -0.53 % $ 2.96 B usaUSA
LENSAR LENSAR
LNSR
$ 5.6 -4.92 % $ 67 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 86.91 0.73 % $ 112 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 15.77 -1.07 % $ 370 M usaUSA
Myomo Myomo
MYO
$ 0.66 -5.91 % $ 27.6 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.42 -1.16 % $ 128 M franceFrance
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 11.74 -0.25 % $ 465 M curacaoCuracao
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Align Technology Align Technology
ALGN
$ 167.92 -2.3 % $ 12.6 B usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
AxoGen AxoGen
AXGN
$ 30.92 -5.27 % $ 1.42 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 202.76 -0.36 % $ 14.3 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Sintx Technologies Sintx Technologies
SINT
$ 2.68 5.93 % $ 7.43 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 31.78 -2.6 % $ 23.8 B britainBritain
Stryker Corporation Stryker Corporation
SYK
$ 332.16 -0.04 % $ 127 B usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.0 -3.27 % $ 847 M usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 24.1 -1.91 % $ 551 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.6 1.69 % $ 37.3 M usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 18.34 -4.36 % $ 1.25 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.68 -0.17 % $ 347 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 61.76 -1.33 % $ 91.4 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 11.07 0.87 % $ 1.66 B usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 10.53 -0.28 % $ 436 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 34.75 1.97 % $ 1.08 B usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 81.0 -0.23 % $ 47.4 B usaUSA